RheumNow Podcast – Back Talk Listener Questions (12.04.20)
Dec 04, 2020
Recent News
-
Read ArticleDr Jack Cush takes questions from RheumNow listeners
Imaging and Large Vessel Vasculitis: Dr. Alexa S. Meara interviews Dr. Kaitlin Quinn #ACR20
https://t.co/CWN2C1P6Fz https://t.co/yHg63VPkiW
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
Pregnancy in SpA Patients: Dr Rachel Tate ( @uptoTate) #ACR20
https://t.co/GPrwd9HU5W https://t.co/TbwN4dZNul
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
#BestACR20Tweets
RT @MeralElRamahiMD : Wonder if you can predict which pts you can taper off bDMARDs? Abst#1538 from Denmark showed that a neg IgM-RF (OR 0.26); low Doppler serum score for 24 jts predicted discontinuation of bDMARDs at 2yr f/u in RA pts w/ DAS28-CRP<2.6.
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
#BestACR20Tweets
RT @bella_mehta :Anakinra in #Stills disease - Dbl blind, placebo controlled RCT in Stills disease total 12pts, 6 placebo, 6 Rx grp. All pts reached ACR70 at wk 2 without fever and sustained it at 12 weeks.
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
Coal Miners and RA: Dr Janet Pope ( @Janetbirdope) reviews abstract #1462 presented at #ACR20.
https://t.co/frZ3uYNsuA https://t.co/nFHmzYA8KS
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
Revist #ACR20. The RheumNow podcast on Day 2, Part I is available for download.
https://t.co/VAPnzYtCIK https://t.co/Pm9g8S1jmn
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
#BestACR20Tweets
RT @RichardPAConway : Dr Benard reports an SLR and meta-analysis of 27 studies comparing 2 rituximab regimes in AAV. 375mg x4 and 1000mg x2 equivalent. Remission in 91% vs 85%.
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
#BestACR20Tweets
RT @doctorRBC : Rheumatology reimbursement by CMS:
""If all goes well, in a few months, you will see a 16% increase in rheumatology.""
- From ACR Advocacy Updates
@RheumNow #ACR20 Abs#5M017
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
Is COVID19 infection bad for rheumatic disease patients? Dr. Jeff Curtis ( @RADoctor) reviews abstract L01 presented at #ACR20.
https://t.co/hm7geJKzNt https://t.co/gAY6k7ywLw
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recommendations for RA: MTX monotherapy conditionally rec over csDMARD dual or triple Rx, MTX+TNFi @RheumNow https://t.co/HUucJOgQgN https://t.co/xJB2zU1y2U
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
Dr. Jack Cush interviews Dr. Petri about the comparative value of lupus anticoagulant vs. other antiphospholipid antibody tests and their role in CVA or MI. #ACR20
https://t.co/IyeRDzw4BC https://t.co/k5LpJ8kkaz
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
#BestACR20Tweets
RT @RHEUMarampa : Novel predictors of early mortality in a cohort of GCA pts from Portugal:
🚩Older age at dx
🚩Tongue claudication
🚩Prior tx w/ anticoag
BP treatment at dx - predictor of early survival.
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 04, 2020
The Lungs: The Alpha and Omega of RA with Dr. Jonathan Kay #ACR20
https://t.co/zhCRaeKOfu https://t.co/zVwgzu9ULs
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 03, 2020
Blood Brain Barrier Leakage in SLE: Dr. Janet Pope ( @Janetbirdope) reviews abstract #1508 from #ACR20 meeting.
https://t.co/JSHyuGtv3O https://t.co/pGaskVnCfi
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 03, 2020
Revisit Day 1 of #ACR20 through the RheumNow podcast. Follow the link below or find us on Apple/Android podcasts.
https://t.co/Hj4uIYzFuL https://t.co/WXecOcVDQR
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 03, 2020
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recs for RA: Use MTX, starting oral but remember MTX tricks to maximize success. Folic acid, split dosing, SubQ all keys per Dr. O'Dell to maximize @RheumNow.
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 03, 2020
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recs for RA: on max tolerated MTX - add bio or tsDMARD conditional recommendation over triple therapy (MTX, HCQ, SSZ). @RheumNow.
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 03, 2020
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recs for RA: discontinue MTX over biologic or tsDMARD in "patients that strongly want to discontinue", conditional recommendation supported by SEAM-RA Abst#939 @RheumNow https://t.co/2Ozvkq4Rjo
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 03, 2020
Check out our latest article from Dr. Janet Pope ( @Janetbirdope)
How are RA patients doing using telemedicine/virtual care?
https://t.co/YffT28OwgY https://t.co/xnAe3lKL8W
Links:
Dr. John Cush @RheumNow ( View Tweet)
Dec 03, 2020
(if this is true) Shame on @expressScripts and forcing money driven biologic changes (from secukinumab to ixekizumab) upon patients and doctors. This is soooo wrong! https://t.co/DYKSItCbYL
Dr. John Cush @RheumNow ( View Tweet)
Dec 03, 2020
From the blog
I have been an investigator for many clinical rheumatology studies over the past two decades but have never been a study subject until now. On October 31, 2020, I enrolled in the phase 3 trial of the Pfizer/BioNTech mRNA vaccine against SARS-CoV2 (protocol C4591001). Here's my experience.
Read Post
Recent Podcasts
RheumNow Podcast – Back Talk Listener Questions (12.04.20)Dec 04, 2020-
Autoinflammatory & Still's Disease PanelNov 24, 2020
-
RheumNow Podcast – ACR 2020 Epilogue (11.20.20)Nov 20, 2020
-
RheumNow Podcast - ACR 2020 Retrospective (11 13 20)Nov 20, 2020
-
RheumNow Podcast - ACR 2020 Retrospective (11 13 20)Nov 13, 2020
